DUB enzymes are emerging as critical regulators in cancer (reviewed in [81]) and neurodegenerative diseases, with their dysfunction linked to Alzheimer's, Parkinson's, and Huntington's diseases (reviewed in [24,82]). This evidence concerns the gene ZUP1 and cancer.